Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Mutant avian erythroblastosis virus with restricted target cell specificity

Abstract

Avian erythroblastosis virus (AEV) induces a fatal erythroblastosis within 2 weeks of intravenous injection in chicks in virtually 100% of cases. In chicks injected intramuscularly, sarcomas frequently develop at the site of injection before the animals die from erythroblastosis1. In vitro, AEV transforms both erythroblasts, derived from bone marrow cultures, and fibroblasts. These effects have been shown to be a general property of AEV and not of separate leukaemia- and sarcoma-inducing forms of the virus2. AEV is defective for replication and can be propagated only in the presence of helper virus. Its transformation specificity is independent of the helper virus used2. It is not clear whether AEV has two different genes controlling transformation of the two types of target cell or whether it has only one gene coding for both. To investigate this question, we looked for mutants of AEV unable to transform one of the two types of target cell. We now describe such a mutant, which is defective for erythroblast transformation but which can still transform fibroblasts.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Graf, T., Fink, D., Beug, H. & Royer-Pokora, B. Cancer Res. 37, 59–63 (1977).

    CAS  PubMed  Google Scholar 

  2. Graf, T., Royer-Pokora, B. & Beug, H. Virology 71, 423–433 (1976).

    Article  CAS  Google Scholar 

  3. Graf, T. Virology 50, 567–578 (1972).

    Article  CAS  Google Scholar 

  4. Hayman, M., Royer-Pokora, B. & Graf, T. Virology 98, 191–199 (1979).

    Article  CAS  Google Scholar 

  5. Dodge, W. H. & Moscovici, C. J. cell. Physiol. 81, 317–386 (1973).

    Article  Google Scholar 

  6. Graf, T. et al. Virology 83, 96–109 (1977).

    Article  CAS  Google Scholar 

  7. Stéhelin, D., Saule, S., Roussel, M., Lagrou, C. & Rommens, Cold Spring Harb. Symp. quant. Biol. 44 (in the press).

  8. Royer-Pokora, B. et al. Cell 13, 751–760 (1978).

    Article  CAS  Google Scholar 

  9. Graf, T., Ade, N. & Beug, H. Nature 257, 496–501 (1978).

    Article  ADS  Google Scholar 

  10. Graf, T., Beug, H., von Kirchbach, A. & Hayman, M. Cold Spring Harb. Symp. quant. Biol. 44 (in the press).

  11. Hanafusa, H., Halpern, C. C., Buchhagen, D. L. & Kawai, S. J. exp. Med. 146, 1735–1747 (1977).

    Article  CAS  Google Scholar 

  12. Stéhelin, D., Varmus, H., Bishop, J. M. & Vogt, P. K. Nature 260, 170–173 (1976).

    Article  ADS  Google Scholar 

  13. Roussel, M. et al. Nature 281, 452–455 (1979).

    Article  ADS  CAS  Google Scholar 

  14. Blug, H. V., Kirchbach, A., Dolderlein, G., Conscience, J. F. & Graf, T. Cell 18, 375–390 (1979).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Royer-Pokora, B., Grieser, S., Beug, H. et al. Mutant avian erythroblastosis virus with restricted target cell specificity. Nature 282, 750–752 (1979). https://doi.org/10.1038/282750a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/282750a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing